Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Novo Nordisk A/S (NVO) had Return on Equity of 11.78% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$11.74B |
|
$3.13B |
|
$2.80B |
|
$8.94B |
|
$8.03B |
|
$3.71B |
|
$287.36M |
|
$4.00B |
|
$4.00B |
|
$3.13B |
|
$3.13B |
|
$3.13B |
|
$3.13B |
|
$3.71B |
|
$4.96B |
|
4.45B |
|
4.45B |
|
$0.70 |
|
$0.70 |
|
| Balance Sheet Financials | |
$28.48B |
|
$30.26B |
|
$51.74B |
|
$80.22B |
|
$36.70B |
|
$13.97B |
|
$16.92B |
|
$53.62B |
|
$26.61B |
|
$9.91B |
|
$26.61B |
|
-- |
|
| Cash Flow Statement Financials | |
$17.46B |
|
$-5.69B |
|
$-9.06B |
|
$2.45B |
|
$5.02B |
|
$2.57B |
|
-- |
|
$-8.11B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.78 |
|
-- |
|
-- |
|
0.34 |
|
0.60 |
|
76.12% |
|
31.59% |
|
31.59% |
|
-- |
|
34.03% |
|
26.68% |
|
$10.93B |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.38 |
|
0.81 |
|
110.88 |
|
|
Return on Equity |
11.78% |
31.60% |
|
3.91% |
|
7.72% |
|
-- |
|
$2.46 |
|
$3.93 |
|